P551 Platelet-to-lymphocyte ratio index for non-invasive assessment of endoscopic activity in small bowel Crohn's disease: application and prospective validation. (30th January 2023)

• Record Type: Journal Article
• Authors: Macedo Silva, V; Ferreira, A I; Lima Capela, T; Arieira, C; Cúrdia Gonçalves, T; Boal Carvalho, P; Dias de Castro, F; Moreira, M J; Cotter, J
• Is Part Of: Journal of Crohn's and colitis. Volume 17(2023)Supplement 1
• Page Start: i680
• Page End: i681
• Publication Date: 2023-01-30
• Subjects: Inflammatory bowel diseases -- Periodicals; 616.344005
• DOI: 10.1093/ecco-jcc/jjac190.0681
• Languages: English
• ISSNs: 1873-9946

Abstract

Abstract: Background: The platelet-to-lymphocyte ratio (PLR) index has recently been a focus of investigation as a reliable marker of inflammation, being shown to have a good accuracy upon predicting endoscopic remission in patients with colonic Crohn's Disease (CD). We aimed to evaluate and validate the discriminative power of PLR index in patients with small bowel CD. Methods: Single center study including patients with isolated small bowel CD (L1 ± L4 disease according to Montreal classification) undergoing small bowel capsule endoscopy (SBCE) for assessment of endoscopic activity. CD endoscopic activity was classified according to the Lewis score (LS) value. Complete blood count, C-reactive protein and fecal calprotectin values were collected within 1 month of SBCE. A retrospective sample was used for initial assessment of PLR index performance, followed by a prospective 2-years application on a distinct sample. Results: The initial sample included 49 and the validation sample 48 patients, both groups being age- and gender-matched. On the initial cohort, PLR index presented a positive moderate correlation with LS (k=0.597; p <0.001), which was stronger than the one found with fecal calprotectin (k=0.525; p =0.001) or C-reactive protein (k=0.321; p =0.029). PLR index presented an excellent accuracy for predicting patients with a moderate-to-severe endoscopic activity (AUC=0.91; 95%CI=0.82-0.99; p <0.001), and a good accuracy for prediction of mucosal healing (AUC=0.74; 95%CI=0.60-0.89; p =0.007). These results were confirmed on the prospective validation cohort, as the correlation of LS with PLR index (k=0.631; p <0.001) was further stronger than with fecal calprotectin (k=0.355; p =0.040) and C-reactive protein (k=0.183; p =0.219). The accuracy of PLR index was confirmed to be excellent for moderate-to-severe endoscopic activity (AUC=0.87; 95%CI=0.76-0.98; p <0.001) and good for mucosal healing (AUC=0.74; 95%CI=0.59-0.87; p <0.001). Conclusion: PLR index demonstrated an excellent acuity in predicting moderate-to-severe disease and good acuity in predicting mucosal healing in patients with small bowel CD, with both associations confirmed on a prospective validation cohort. Our findings establish this index as a promising and easy-to-apply tool for non-invasive and regular follow-up of patients with small bowel CD.